Bcr1 functions downstream of Ssd1 to mediate antimicrobial peptide resistance in Candida albicans

Sook-In Jung1, Jonathan S Finkel, Norma V Solis

  • 1Division of Infectious Diseases, Chonnom National University Medical School, Gwangju, South Korea.

Eukaryotic Cell
|January 15, 2013
PubMed

Insights

The regulatory protein Bcr1 helps Candida albicans resist antimicrobial peptides, functioning downstream of Ssd1. This resistance involves maintaining mitochondrial energy and reducing membrane damage.

Area of Science:

  • Mycology
  • Molecular Biology
  • Host-Pathogen Interactions

Background:

  • Candida albicans must evade host defense peptides for colonization and disease.
  • The regulatory protein Ssd1 is known to control antimicrobial peptide resistance in C. albicans.

Purpose of the Study:

  • To identify additional genes involved in antimicrobial peptide susceptibility in C. albicans.
  • To elucidate the relationship between Ssd1 and other resistance mechanisms.

Main Methods:

  • Comparative analysis of gene deletion mutants (bcr1Δ/Δ and ssd1Δ/Δ) for antimicrobial peptide susceptibility.
  • Assessment of mitochondrial membrane potential and plasma membrane permeability.
  • Analysis of BCR1 mRNA expression and complementation studies.

Main Results:

  • The bcr1Δ/Δ mutant exhibited increased susceptibility to antimicrobial peptides, similar to the ssd1Δ/Δ mutant.
  • Bcr1 and Ssd1 likely function in the same pathway, with Bcr1 acting downstream of Ssd1.
  • Bcr1 is crucial for maintaining mitochondrial energetics and reducing membrane permeability.

Conclusions:

  • Bcr1 is a key regulator of antimicrobial peptide resistance in Candida albicans.
  • Bcr1 functions downstream of Ssd1, likely through novel target genes.
  • Understanding this pathway offers potential targets for antifungal strategies.

Related Concept Videos

The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this defense.
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...